Dr. Rebeca D. Monk, MD

Dr. Monk practices at Smh Infusion Center at Highland Hos - Outpatient Oncology at Hh - HOPD in Rochester, New York.

Dr. Monk's NPI, 1679513535, was assigned on June 8, 2006. Dr. Monk graduated from University of Missouri, Columbia School of Medicine in 1988. Dr. Monk holds New York license 180748.

Dr. Monk's primary practice is Smh Infusion Center at Highland Hos - Outpatient Oncology at Hh - HOPD, at 1000 South Ave, Rochester, NY 14620.

Dr. Monk's primary practice is Smh Infusion Center at Highland Hos - Outpatient Oncology at Hh - HOPD in Rochester, New York. Dr. Monk is also affiliated with Highland Hospital. The medical group on file is Highland Hospital. Dmand AI also links Dr. Monk to 1 more hospital, 2 dialysis centers and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Monk practices, 5 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Monk's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Monk is licensed in New York.

CMS data shows 109 Medicare services from Dr. Monk across 5 procedure codes in 2024, for 73 Medicare patients. Medicare paid $6,538 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 73 Medicare patients who saw Dr. Monk in 2024. The largest group is 75 to 84, with 24 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 45% are also on Medicaid. Their average risk score is 5.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Monk's median patient age at 71, with 53% women.

In 2024, Dr. Monk wrote 453 Medicare Part D claims for 75 patients. 86% of them were for generic drugs. CMS names the drug for 339 of them, across 14 drugs with 11 or more claims each, at $74,362 in total drug cost. In 2023, CMS named 347 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Monk for performance year 2024, reported as part of a group. Dr. Monk accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Monk as offering telehealth.

Dmand AI links 5 papers to Dr. Monk, published from 2011 to 2025. 2016 was the busiest year, with 2. The most frequent topics are Renal Insufficiency, Chronic. Dr. Monk has published most often in Clin J Am Soc Nephrol. Dr. Monk's most frequent co-authors are Scott E. Liebman, MD, Bassim Assioun, MD and Ted D. Barnett, MD.

CMS Open Payments shows 24 general payments to Dr. Monk from 4 drug and device companies from 2018 to 2025. Education make up the largest share, 47% of the total. Boston Scientific Corporation paid the most, $95.

Dr. Monk graduated from University of Missouri, Columbia School of Medicine in 1988.